- Home
- WBX vs COYA Comparison
WBX vs COYA Comparison
Compare WBX & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- COYA
- Stock Information
- Founded
- WBX 2015
- COYA 2020
- Country
- WBX Spain
- COYA United States
- Employees
- WBX N/A
- COYA N/A
- Industry
- WBX Industrial Specialties
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- WBX Consumer Discretionary
- COYA Health Care
- Exchange
- WBX Nasdaq
- COYA Nasdaq
- Market Cap
- WBX 119.6M
- COYA 98.5M
- IPO Year
- WBX N/A
- COYA 2022
- Fundamental
- Price
- WBX $0.51
- COYA $6.41
- Analyst Decision
- WBX Buy
- COYA Strong Buy
- Analyst Count
- WBX 3
- COYA 4
- Target Price
- WBX $1.17
- COYA $16.25
- AVG Volume (30 Days)
- WBX 331.8K
- COYA 93.4K
- Earning Date
- WBX 02-26-2025
- COYA 03-18-2025
- Dividend Yield
- WBX N/A
- COYA N/A
- EPS Growth
- WBX N/A
- COYA N/A
- EPS
- WBX N/A
- COYA N/A
- Revenue
- WBX $179,622,844.00
- COYA $9,554,315.00
- Revenue This Year
- WBX $18.23
- COYA N/A
- Revenue Next Year
- WBX $21.57
- COYA $56.22
- P/E Ratio
- WBX N/A
- COYA N/A
- Revenue Growth
- WBX 16.10
- COYA N/A
- 52 Week Low
- WBX $0.41
- COYA $4.75
- 52 Week High
- WBX $1.73
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- WBX 49.90
- COYA 52.07
- Support Level
- WBX $0.45
- COYA $5.85
- Resistance Level
- WBX $0.62
- COYA $7.25
- Average True Range (ATR)
- WBX 0.04
- COYA 0.51
- MACD
- WBX 0.01
- COYA -0.04
- Stochastic Oscillator
- WBX 37.43
- COYA 32.94
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.